KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $29.7 million.

  • Fulgent Genetics' Net Cash Flow rose 51948.95% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.7 million, marking a year-over-year increase of 32854.57%. This contributed to the annual value of -$42.1 million for FY2024, which is 33260.65% down from last year.
  • Latest data reveals that Fulgent Genetics reported Net Cash Flow of $29.7 million as of Q3 2025, which was up 51948.95% from $20.6 million recorded in Q2 2025.
  • Fulgent Genetics' Net Cash Flow's 5-year high stood at $188.2 million during Q1 2022, with a 5-year trough of -$213.7 million in Q2 2022.
  • Over the past 5 years, Fulgent Genetics' median Net Cash Flow value was $10.4 million (recorded in 2024), while the average stood at $1.6 million.
  • Examining YoY changes over the last 5 years, Fulgent Genetics' Net Cash Flow showed a top increase of 250733.08% in 2021 and a maximum decrease of 64204.86% in 2021.
  • Over the past 5 years, Fulgent Genetics' Net Cash Flow (Quarter) stood at -$50.0 million in 2021, then tumbled by 77.9% to -$89.0 million in 2022, then surged by 114.89% to $13.3 million in 2023, then tumbled by 120.86% to -$2.8 million in 2024, then skyrocketed by 1176.19% to $29.7 million in 2025.
  • Its last three reported values are $29.7 million in Q3 2025, $20.6 million for Q2 2025, and $12.1 million during Q1 2025.